UPDATE : Monday, September 7, 2020
상단여백
Jeil releases P3 clinical trial results for anti-hypertension treatment
Jeil Pharmaceutical said Monday that it has published the phase 3 clinical ...
by Lee Han-soo  |  2019-03-11 14:03
라인
Officials to visit Gore to get artificial blood vessels for children
Korean health officials said they would soon visit the headquarters of W.L....
by Lee Hye-seon  |  2019-03-11 11:20
라인
ResMed acquires HB Healthcare
ResMed, a U.S.-based medical equipment company that primarily deals with eq...
by Lee Han-soo  |  2019-03-08 17:49
라인
Daewoong’s pulmonary fibrosis treatment wins government support
Daewoong Pharmaceutical said Friday that the Korea Drug Development Fund (K...
by Lee Han-soo  |  2019-03-08 16:57
라인
Yonsei, AITRICS to establish AI-based emergency prediction system
Yonsei University Health System (YUHS) said Thursday that it has signed an ...
by Lee Han-soo  |  2019-03-08 16:09
라인
Gilead, Yuhan to co-promote Biktarvy
Yuhan Corp. said Friday that it has signed an agreement with Gilead Science...
by Lee Han-soo  |  2019-03-08 15:32
라인
Secondhand smoke raises risk for chronic kidney disease
Exposure to secondhand smoke can elevate the risk for chronic kidney diseas...
by Lee Hye-seon  |  2019-03-08 15:31
라인
Roche Korea’s combo therapy gets nod as 1st-line lung cancer therapy
Roche Korea said Friday that its combination therapy -- Tecentriq and Alece...
by Lee Han-soo  |  2019-03-08 14:38
라인
17% of hospital workers confirmed with latent tuberculosis
About 17 percent of employees working at local medical institutions were co...
by Kwak Sung-sun  |  2019-03-08 14:36
라인
Sanofi Genzyme’s Gaucher disease treatment gets more insurance benefit
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that the Minist...
by Lee Han-soo  |  2019-03-07 16:22
라인
Daewoong marks record-high sales in 2018
Daewoong Pharmaceutical said Wednesday that it recorded sales of 943.5 bill...
by Lee Han-soo  |  2019-03-07 16:01
라인
When will NOAC reversal agents be available in Korea?
Several drugs that reverse the blood thinning effect of non-vitamin K oral ...
by Kim Yun-mi  |  2019-03-07 15:52
라인
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned
The government has banned the off-label use of sirolimus, an immunosuppress...
by Lee Hye-seon  |  2019-03-07 15:10
라인
Celltrion Healthcare wins biosimilar bids in SE Asia
Celltrion Healthcare said that it won the bids for Singapore’s infliximab b...
by Lee Han-soo  |  2019-03-07 14:25
라인
Amgen’s Xgeva solves adverse effect problems
Amgen’s Xgeva (ingredient: denosumab) has resolved adverse effect issues fo...
by Lee Han-soo  |  2019-03-07 14:25
라인
‘Korean drugmakers can tap US generic market’
Korean pharmaceutical companies would find it better to utilize long-accumu...
by Jeong Sae-im  |  2019-03-07 11:54
라인
SNUBH implements smart surgical system
Seoul National University Bundang Hospital (SNUBH) said that it has built a...
by Lee Han-soo  |  2019-03-06 17:37
라인
Foreign patients mostly satisfied with Korea’s healthcare service
International patients who received treatment at Korean medical institution...
by Lee Han-soo  |  2019-03-06 17:05
라인
Interagency new drug development project generates ₩7.3 trillion license deals
The government said the “pan-governmental full-cycle new drug development p...
by Kwak Sung-sun  |  2019-03-06 16:24
라인
EzCareTech to speed up global presence with IPO
EzCareTech expressed its aspiration to become a global health networking le...
by Lee Han-soo  |  2019-03-06 14:58
여백
여백
여백
Back to Top